260 results
Page 6 of 13
8-K
EX-99.1
b9rfxs
2 May 13
Repligen Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
z414oy
7 Mar 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
1ca6e 901k7osob
8 Nov 12
Repligen Reports Third Quarter 2012 Financial Results
12:00am
8-K
cq8m7 mtly
26 Oct 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
r8j5 0w5a
21 Sep 12
Repligen Appoints Jonathan I. Lieber as CFO
12:00am
8-K
EX-99.1
xlxt9dgx p63v
2 Aug 12
Reports Second Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
84ypkal t9klp3r
22 Jun 12
Repligen Receives Complete Response Letter from FDA for RG1068 NDA
12:00am
8-K
EX-99.1
khw2kete2m4
7 May 12
Repligen Announces Support of Amended Stockholder Proposal
12:00am
8-K
EX-99.1
49b t3a8u52fm
26 Apr 12
FDA Cancels Advisory Committee Meeting
12:00am
8-K
EX-99.1
bhe1f9pwl 8jz69o9fk
5 Mar 12
Vice President, Market Development
12:00am
8-K
EX-99.1
xk60a
21 Feb 12
Conference Call Today 10 a.m. EST
12:00am